Sartorius AG Stock Börse Stuttgart

Equities

SRT3

DE0007165631

Advanced Medical Equipment & Technology

Market Closed - Börse Stuttgart 15:59:02 2024-05-03 EDT 5-day change 1st Jan Change
285.1 EUR +1.42% Intraday chart for Sartorius AG -3.46% -14.98%

Financials

Sales 2024 * 3.58B 3.85B 5.27B Sales 2025 * 4.02B 4.33B 5.92B Capitalization 17.53B 18.86B 25.81B
Net income 2024 * 214M 230M 315M Net income 2025 * 343M 369M 505M EV / Sales 2024 * 6.03 x
Net Debt 2024 * 4.05B 4.36B 5.97B Net Debt 2025 * 3.82B 4.11B 5.62B EV / Sales 2025 * 5.31 x
P/E ratio 2024 *
77.4 x
P/E ratio 2025 *
52.2 x
Employees -
Yield 2024 *
0.3%
Yield 2025 *
0.4%
Free-Float 35.03%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.52%
Current month+1.10%
1 month-18.33%
3 months-13.84%
6 months+10.80%
Current year-14.05%
More quotes
1 week
280.20
Extreme 280.2
295.80
1 month
265.00
Extreme 265
352.90
3 years
216.10
Extreme 216.1
629.60
5 years
157.40
Extreme 157.4
629.60
10 years
18.86
Extreme 18.85875
629.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 99-04-30
Chief Tech/Sci/R&D Officer 59 94-12-31
Chief Operating Officer 67 00-12-31
Members of the board TitleAgeSince
Director/Board Member 69 19-12-31
Director/Board Member 75 11-11-28
Director/Board Member 58 17-04-05
More insiders
Date Price Change Volume
24-05-03 285.1 +1.42% 42
24-05-02 281.1 -0.32% 890
24-04-30 282 -2.99% 421
24-04-29 290.7 +0.41% 1,096
24-04-26 289.5 +2.62% 343

Delayed Quote Börse Stuttgart, May 03, 2024 at 03:59 pm

More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
284.3 EUR
Average target price
330.8 EUR
Spread / Average Target
+16.36%
Consensus